Oscar Health (OSCR) Depreciation & Amortization (CF) (2020 - 2026)

Oscar Health (OSCR) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $7.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 4.28% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.2 million (down 5.9% YoY) and the FY2025 annual result came in at $28.9 million, down 9.97% from the prior year.
• Depreciation & Amortization (CF) fell to $7.0 million in Q1 2026, from $7.9 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $9.2 million in Q3 2023 to a low of $3.7 million in Q2 2022.
• A 5-year average of $6.7 million and a median of $7.3 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 139.01% — and 2024, when it declined 18.4%.
• Tracing OSCR's Depreciation & Amortization (CF) over 5 years: stood at $3.7 million in 2022, then soared by 107.28% to $7.7 million in 2023, then advanced by 18.68% to $9.2 million in 2024, then dropped by 14.15% to $7.9 million in 2025, then declined by 11.03% to $7.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $7.0 million (Q1 2026), $7.9 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.